clinical trials
No description yet: the sentence for this tag has not been written. 16 records carry it: 16 people. Also written “clinical-trials”; the spellings share this page.
Related tags
16 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Alexis Cortot President · Intergroupe Francophone de Cancérologie Thoracique Lille pulmonologist and thoracic oncologist who presides over the IFCT, France's academic lung cancer trials group. | Non-small-cell lung cancer, Small-cell lung cancer | none | leadership, clinician-scientist, lung cancer | ||
Christos Karapetis Board Director · Australasian Gastro-Intestinal Trials Group Australian medical oncologist whose landmark NEJM analysis showed KRAS mutation predicts lack of benefit from cetuximab in colorectal cancer. | Colorectal cancer | none | clinician-scientist, colorectal cancer | ||
Franco Cavalli President of the Board, International Extranodal Lymphoma Study Group · International Extranodal Lymphoma Study Group Swiss oncologist who presides over the board of the international study group that runs clinical trials in lymphomas arising outside the lymph nodes. | Diffuse large B-cell lymphoma | none | leadership, clinician-scientist, lymphoma | ||
Geoff Parnell Chair, Board of Directors · Australasian Gastro-Intestinal Trials Group Oesophageal cancer survivor and business executive who chairs the board of GI Cancer Trials (the Australasian Gastro-Intestinal Trials Group). | Oesophageal cancer | none | leadership, gastrointestinal cancer | ||
Jin Seok Ahn President (14th) · Korean Cancer Study Group Medical oncologist serving as 14th President of the Korean Cancer Study Group, Korea's main academic cooperative trials group. | Non-small-cell lung cancer | none | leadership, clinician-scientist, lung cancer | ||
Mafalda Oliveira President (Presidenta) · SOLTI Cancer Research Group Barcelona breast oncologist who leads SOLTI, the Spanish academic breast cancer research group, and co-authors pivotal endocrine therapy trials. | HR-positive / HER2-negative breast cancer | none | leadership, clinician-scientist, breast cancer | ||
Marco Vignetti President · GIMEMA Haematologist who presides over GIMEMA, Italy's adult haematological malignancies cooperative group, and co-authored its chemotherapy-free Ph+ ALL trial. | Acute lymphoblastic leukaemia, Acute myeloid leukaemia | none | leadership, clinician-scientist, leukaemia | ||
Michael Gnant President · Austrian Breast & Colorectal Cancer Study Group Viennese surgical oncologist who presides over the ABCSG and has led landmark adjuvant breast cancer trials such as ABCSG-12, ABCSG-18 and PALLAS. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, breast cancer | ||
Nicolas Penel Directeur Général (Director General) of Institut Bergonié · Institut Bergonié Medical oncologist and sarcoma specialist who directs Institut Bergonié, the regional cancer centre for Nouvelle-Aquitaine in Bordeaux. | Sarcomas | none | leadership, clinician-scientist, sarcoma | ||
Nobuyuki Yamamoto Chairman · West Japan Oncology Group Lung cancer specialist at Wakayama Medical University who chairs the West Japan Oncology Group cooperative trials network. | Non-small-cell lung cancer, Small-cell lung cancer | none | leadership, clinician-scientist, lung cancer | ||
Norman Wolmark Chairman · NSABP Foundation Surgical oncologist and long-time Chairman of the NSABP, whose trials established breast-conserving surgery and adjuvant therapy standards in breast and colorectal cancer. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Colorectal cancer | none | leadership, clinician-scientist, breast cancer | ||
Priya Rastogi Chief Executive Officer & Medical Director · NSABP Foundation Pittsburgh medical oncologist who serves as CEO and Medical Director of the NSABP Foundation, leading its breast cancer trial portfolio. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, breast cancer | ||
Purnima Sundaresan President · TROG Cancer Research Sydney radiation oncologist who is President of TROG Cancer Research, Australasia's radiation oncology trials group. | none | none | leadership, clinician-scientist, radiotherapy | ||
Rebecca Li Executive Director and CEO · Vivli Leads Vivli, the non-profit global platform for sharing anonymised individual participant data from clinical trials, including oncology studies. | none | none | leadership, data sharing | ||
Samantha Oakes CEO · ANZUP Cancer Trials Group Cancer biologist turned research executive who serves as CEO of the ANZUP Cancer Trials Group. | Prostate cancer | none | leadership, genitourinary oncology | ||
Sébastien Armanet Directeur Général (Director General) of ARCAGY-GINECO · ARCAGY-GINECO Director General who runs the operational team of ARCAGY-GINECO, the French non-profit academic research group for gynaecological and metastatic breast cancers. | Ovarian cancer, Endometrial cancer, Cervical cancer | none | leadership, cooperative-group |
